Andrea Favre-Bulle

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Basal Cell Carcinoma

Top Venues

Journal of medical economics

PharmacoEconomics - open

This page only lists publications with an associated author ORCID identifier.

Publications

Cillian Copeland, Nikolaos Kotsopoulos, Andrea Favre-Bulle, Goran Bencina, Demet Sönmez, Stina Salomonsson
Assessing the fiscal consequences of novel and existing treatments for triple negative breast cancer in Switzerland by applying a government perspective framework. Journal of medical economics (2024)
Cillian Copeland, Nikolaos Kotsopoulos, Andrea Favre-Bulle, Goran Bencina, Demet Sönmez, Stina Salomonsson
Assessing the fiscal consequences of novel and existing treatments for triple negative breast cancer in Switzerland by applying a government perspective framework. Journal of medical economics 27 (1) (2024)
Andrea Favre-Bulle, Goran Bencina, Shujing Zhang, Ruixuan Jiang, Daniel Andritschke, Arjun Bhadhuri
Cost-effectiveness of pembrolizumab as an adjuvant treatment for patients with resected stage IIB or IIC melanoma in Switzerland. Journal of medical economics (2023)
Andrea Favre-Bulle, Goran Bencina, Shujing Zhang, Ruixuan Jiang, Daniel Andritschke, Arjun Bhadhuri
Cost-effectiveness of pembrolizumab as an adjuvant treatment for patients with resected stage IIB or IIC melanoma in Switzerland. Journal of medical economics (2023)
Andrea Favre-Bulle, Min Huang, Amin Haiderali, Arjun Bhadhuri
Cost-Effectiveness of Neoadjuvant Pembrolizumab plus Chemotherapy Followed by Adjuvant Pembrolizumab in Patients with High-Risk, Early-Stage, Triple-Negative Breast Cancer in Switzerland. PharmacoEconomics - open (2023)
Andrea Favre-Bulle, Goran Bencina, Shujing Zhang, Ruixuan Jiang, Daniel Andritschke, Arjun Bhadhuri
Cost-effectiveness of pembrolizumab as an adjuvant treatment for patients with resected stage IIB or IIC melanoma in Switzerland. Journal of medical economics 26 (1) (2023)